"Designing Growth Strategies is in our DNA"

Allergy Immunotherapy Market Size, Share & Industry Analysis, By Type (Subcutaneous Immunotherapy, and Sublingual Immunotherapy), By Application (Allergic Rhinitis, Allergic Asthma, and Others), By Distribution Channel (Hospital Pharmacies, and Retail Pharmacies & Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI100727

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 10.3% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

By Application

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies & Online Pharmacies

By Geography

  • North America (By Type, By Application, By Distribution Channel, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Poland
    • Sweden
    • Norway
    • Denmark
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 129
Consulting Services
    How will you benefit from our consulting services ?